214 related articles for article (PubMed ID: 24801051)
21. Measurement of annexin V uptake and lactadherin labeling for the quantification of apoptosis in adherent Tca8113 and ACC-2 cells.
Hu T; Shi J; Jiao X; Zhou J; Yin X
Braz J Med Biol Res; 2008 Sep; 41(9):750-7. PubMed ID: 18820763
[TBL] [Abstract][Full Text] [Related]
22. FVIII binding to PS membranes differs in the activated and non-activated form and can be shielded by annexin A5.
Engelke H; Lippok S; Dorn I; Netz RR; Rädler JO
J Phys Chem B; 2011 Nov; 115(44):12963-70. PubMed ID: 21954889
[TBL] [Abstract][Full Text] [Related]
23. Peripheral protein organization and its influence on lipid diffusion in biomimetic membranes.
Vats K; Knutson K; Hinderliter A; Sheets ED
ACS Chem Biol; 2010 Apr; 5(4):393-403. PubMed ID: 20175560
[TBL] [Abstract][Full Text] [Related]
24. Advantages of the phosphatidylserine-recognizing peptide PSP1 for molecular imaging of tumor apoptosis compared with annexin V.
Kim S; Bae SM; Seo J; Cha K; Piao M; Kim SJ; Son HN; Park RW; Lee BH; Kim IS
PLoS One; 2015; 10(3):e0121171. PubMed ID: 25803297
[TBL] [Abstract][Full Text] [Related]
25. The role of annexin A5 in the modulation of the immune response against dying and dead cells.
Munoz LE; Frey B; Pausch F; Baum W; Mueller RB; Brachvogel B; Poschl E; Rödel F; von der Mark K; Herrmann M; Gaipl US
Curr Med Chem; 2007; 14(3):271-7. PubMed ID: 17305532
[TBL] [Abstract][Full Text] [Related]
26. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
[TBL] [Abstract][Full Text] [Related]
27. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation.
Dillon SR; Mancini M; Rosen A; Schlissel MS
J Immunol; 2000 Feb; 164(3):1322-32. PubMed ID: 10640746
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
Yagle KJ; Eary JF; Tait JF; Grierson JR; Link JM; Lewellen B; Gibson DF; Krohn KA
J Nucl Med; 2005 Apr; 46(4):658-66. PubMed ID: 15809489
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of a radiolabeled bis-zinc(II)-cyclen complex as a potential probe for in vivo imaging of cell death.
Wang H; Wu Z; Li S; Hu K; Tang G
Apoptosis; 2017 Apr; 22(4):585-595. PubMed ID: 28084570
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylserine targeting for diagnosis and treatment of human diseases.
Schutters K; Reutelingsperger C
Apoptosis; 2010 Sep; 15(9):1072-82. PubMed ID: 20440562
[TBL] [Abstract][Full Text] [Related]
31. Annexin A5 as a targeting agent for cancer treatment.
Woodward A; Faria GNF; Harrison RG
Cancer Lett; 2022 Oct; 547():215857. PubMed ID: 35940392
[TBL] [Abstract][Full Text] [Related]
32. Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine.
Smith C; Gibson DF; Tait JF
BMC Biochem; 2009 Feb; 10():5. PubMed ID: 19222854
[TBL] [Abstract][Full Text] [Related]
33. Externalization of endogenous annexin A5 participates in apoptosis of rat cardiomyocytes.
Monceau V; Belikova Y; Kratassiouk G; Charue D; Camors E; Communal C; Trouvé P; Russo-Marie F; Charlemagne D
Cardiovasc Res; 2004 Dec; 64(3):496-506. PubMed ID: 15537503
[TBL] [Abstract][Full Text] [Related]
34. Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cells.
van Tilborg GA; Geelen T; Duimel H; Bomans PH; Frederik PM; Sanders HM; Deckers NM; Deckers R; Reutelingsperger CP; Strijkers GJ; Nicolay K
Contrast Media Mol Imaging; 2009; 4(1):24-32. PubMed ID: 19137542
[TBL] [Abstract][Full Text] [Related]
35. Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane.
Wang J; Liu J; Cao Y; Hu M; Hua Z
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257055
[No Abstract] [Full Text] [Related]
36. The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.
Kietselaer BL; Hofstra L; Dumont EA; Reutelingsperger CP; Heidendal GA
Q J Nucl Med; 2003 Dec; 47(4):349-61. PubMed ID: 14973424
[TBL] [Abstract][Full Text] [Related]
37. Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.
Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Linder S; Arnér ES; Stone-Elander S
Biochim Biophys Acta; 2013 Mar; 1830(3):2562-73. PubMed ID: 23262140
[TBL] [Abstract][Full Text] [Related]
38. Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
Haeckel A; Ascher L; Beindorff N; Prasad S; Garczyńska K; Guo J; Schellenberger E
Apoptosis; 2021 Oct; 26(9-10):534-547. PubMed ID: 34405304
[TBL] [Abstract][Full Text] [Related]
39. In vitro modeling of matrix vesicle nucleation: synergistic stimulation of mineral formation by annexin A5 and phosphatidylserine.
Genge BR; Wu LN; Wuthier RE
J Biol Chem; 2007 Sep; 282(36):26035-45. PubMed ID: 17613532
[TBL] [Abstract][Full Text] [Related]
40. Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Rongen GA; Oyen WJ; Ramakers BP; Riksen NP; Boerman OC; Steinmetz N; Smits P
Circulation; 2005 Jan; 111(2):173-8. PubMed ID: 15623546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
